JAMA 1984-05-04

Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.

L S Goodman, M M Wintrobe, W Dameshek, M J Goodman, A Gilman, M T McLennan

文献索引：JAMA 251(17) , 2255-61, (1984)

结构式	名称/CAS号	分子式	全部文献
	三(2-氯乙基)胺盐酸盐 CAS:817-09-4	C₆H₁₃Cl₄N

Identification of the nitrogen-based blister agents bis(2-ch...
2000-12-01
[J. Mass Spectrom. 35(12) , 1460-9, (2000)]

Ameliorative effect of DRDE 07 and its analogues on the syst...
2010-09-01
[Hum. Exp. Toxicol. 29(9) , 747-55, (2010)]

Carcinogenicity of trichloromethine hydrochloride (TS-160 Sp...
1981-01-01
[Neoplasma 28(5) , 565-74, (1981)]

Treatment of advanced Hodgkin's disease with modified MOPP r...
1989-01-01
[Neoplasma 36(6) , 709-18, (1989)]

The effects of radiation and alkylating agents on chromatin ...
1991-02-01
[Gen. Physiol. Biophys. 10(1) , 41-8, (1991)]